Diabetes mellitus (DM) is an important risk factor for acute myocardial infarction (AMI) and a
frequent co-morbidity in patients hospitalized with AMI, being present in about 30% of cases …

Acute myocardial infarction with cardiogenic shock (AMI-CS) is associated with high
mortality and morbidity despite advancements in cardiovascular care. AMI-CS is associated …

Background Diabetes mellitus (DM) is associated with an increased mortality risk in patients
hospitalized with acute myocardial infarction (AMI); however, no studies have investigated …

Background Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …

Background High-sensitivity C-reactive protein (hs-CRP) elevation frequently occurs in
acute myocardial infarction (AMI) and is associated with adverse outcomes. Since diabetes …

Abstract Aims/Introduction The predictive value of admission hyperglycemia in the long‐term
prognosis of acute myocardial infarction patients is still controversial. We aimed to …

Background. Young patients with type 2 diabetes mellitus (DM) and acute myocardial
infarction (AMI) have high long‐term all‐cause and cardiovascular mortality rates. We aimed …

Background Continuous glucose monitoring (CGM) shows in more detail the glycaemic
pattern of diabetic subjects and provides several new parameters (“glucometrics”) to assess …

Background The harmful effect of diabetes mellitus (DM) on mortality in patients with acute
myocardial infarction (AMI) remains controversial. Furthermore, few studies focused on …

Diabetes mellitus (DM) and peripheral artery disease (PAD) are two clinical entities closely
associated. They share many pathophysiological pathways such as inflammation …